Already a DIA Member? Sign in. Not a member? Join.

Sign in

Forgot User ID? or Forgot Password?

Not a Member?

Create Account and Join

Virtual Event

Jun 14, 2020 9:00 AM - Jun 18, 2020 5:00 PM

(Eastern Standard Time)

Fort Washington, PA 19034

DIA 2020 Global Annual Meeting

ON DEMAND - Microbiome Therapies Beyond Fecal Microbiota Transplantation: Challenges and Opportunities

Session Chair(s)

Anita  Nelsen

Anita Nelsen

Executive Vice President, Translational Medicine

Parexel, United States

Live biotherapeutics, an emerging new class of drug products which leverage living microorganisms, have potential to prevent, treat or cure diseases or conditions. Leveraging next generation sequencing and other -omics technologies researchers are gaining a greater understanding of the human microbiome and the role it plays in human health, drug metabolism and disease. Experimentation with fecal transplants have shown promise in treating patients with C. difficile infection and IBD and researchers believe there are many more opportunities to significantly improve human health. This session will explore the unique challenges in developing this new class of precision medicines.

Learning Objective : Explain the microbiome and how it is being used to develop a new class of personalized medicines; Describe the unique clinical development, requlatory, manufacturing, and quality challenges faced when developing live biotherapeutics and approaches to overcome these challenges..

Speaker(s)

Anmol  Grover, PhD

Microbiome Therapies Beyond Fecal Microbiota Transplantation: Solutions to Address Challenges

Anmol Grover, PhD

Halloran Consulting Group, United States

Clinical Strategy Consultant

Have an account?

Be informed and stay engaged.

Don't miss an opportunity - join our mailing list to stay up to date on DIA insights and events.